| Literature DB >> 27118628 |
Gustavo H Dayan1, Naglaa Mohamed1, Ingrid L Scully1, David Cooper1, Elizabeth Begier1, Joseph Eiden1, Kathrin U Jansen1, Alejandra Gurtman1, Annaliesa S Anderson1.
Abstract
Staphylococcus aureus is both a commensal organism and also an important opportunistic human pathogen, causing a variety of community and hospital-associated pathologies, such as bacteremia-sepsis, endocarditis, pneumonia, osteomyelitis, arthritis and skin diseases. The resurgence of S. aureus during the last decade in many settings has been facilitated not only by bacterial antibiotic resistance mechanisms but also by the emergence of new S. aureus clonal types with increased expression of virulence factors and the capacity to neutralize the host immune response. Prevention of the spread of S. aureus infection relies on the use of contact precautions and adequate procedures for infection control that so far have not been fully effective. Prevention using a prophylactic vaccine would complement these processes, having the potential to bring additional, significant progress toward decreasing invasive disease due to S. aureus.Entities:
Keywords: Staphylococcus aureus; infection; pathophysiology; prevention; vaccine
Mesh:
Substances:
Year: 2016 PMID: 27118628 DOI: 10.1080/14760584.2016.1179583
Source DB: PubMed Journal: Expert Rev Vaccines ISSN: 1476-0584 Impact factor: 5.217